
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
reMYND NV is a dynamic biotech company located in Leuven (Belgium) that actively drives R&D in the field of protein misfolding diseases, among others Alzheimers disease (AD) and Parkinsons disease (PD). The company consists of two independently managed units. The Drug Discovery and Development Unit focuses on disease-modifying treatments for among others AD and PD (counteracting TAU and aSyn toxicity, respectively). The Contract Research Unit offers extensive experience in the testing of experimental Alzheimer therapies in its unique and proprietary transgenic mouse models. For more information please visit www.remynd.com Alternatively, please contact Koen De Witte (Managing Director - pipeline@remynd.com) to...
Protein misfolding diseases,diabetes,alzheimer's disease,parkinson's disease,transgenic alzheimer models,drug development,contract research,pre-clinical in vivo drug testing,and cro
Remynd nv operates in the Biotechnology industry.
Remynd nv's revenue is 11m - 100m
Remynd nv has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.